PACE® Nano Genotyping Master Mix

Advanced performance at ultra-low reaction volumes, delivering consistent, cost-effective PCR genotyping for high-throughput, miniaturised and automated workflows.


Step into the future of high-throughput PCR genotyping with PACE Nano! Backed by decades of expertise in high-throughput genotyping reagent manufacturing, our groundbreaking product is engineered specifically to excel in low and ultra-low volume reactions. Say goodbye to performance variability as PACE Nano Genotyping Master Mix and PACE Genotyping Assays raise the bar for reliability and performance in the field.

With superior cost-effectiveness and versatile compatibility, PACE Nano Genotyping Master Mix ensures consistent results across diverse platforms, samples, and markers, including 384- and 1536-well PCR, Array Tape™, SNPline™ and Gene Mathematica from HC Scientific, available from 3CR Bioscience, supporting reaction volumes as low as 0.8 µL. Join the revolution today and elevate your research with PACE Nano.


  • Cost-Effective: Produce more high-quality data faster and at a much lower cost compared to competitors, reducing reagent expenses without compromising on quality.
  • Optimised for Low and Ultra-Low Volume PCR Genotyping: PACE Nano Genotyping Master Mix is specifically tailored for enhanced performance in miniaturised PCR genotyping, for reaction volumes as low as 0.8 µL and for high-throughput and automated processing with accurate, reliable results.
  • Consistent Data Across Assays: PACE Nano reduces variability in assay performance, enhancing the robustness and efficiency of high throughput, miniaturised and automated workflows.
  • Backed by 20 Years of Expertise: Designed and manufactured with 20 years of experience in high-throughput genotyping reagents, ensuring reliability and quality.
  • Scalability: Our PACE® genotyping reagents are platform agnostic, so you can adapt to changing throughput requirements effortlessly, ensuring flexibility and efficiency at every stage of your genotyping workflow.
  • PACE Nano Global Product Support: Benefit from a stable supply chain and unparalleled global product support, tailored to your needs regardless of size or throughput. Supported by the highest quality-assurance processes, ensuring reliability and consistency.




  • qPCR machine or Thermocycler + Fluorescent plate reader
  • PCR plate or equivalent and appropriate optically clear seal
  • Template DNA
  • PCR-grade water
  • Genotyping assays

For Research and Development purposes only. Not for diagnostic use.

Legal Information
Array Tape™ and SNPline™ are trademarks of LGC Biosearch Technologies


Can PACE Nano Genoytping Master Mix be used with different types of DNA samples?

Yes, PACE Nano Genotyping Master Mix demonstrates excellent performance with various DNA sample types, including wet or dry DNA samples, and even crude DNA extractions.

How does PACE Nano Genotyping Master Mix contribute to cost savings?

3CR is committed to manufacturing low-cost reagents costs while ensuring the highest levels of performance, quality assurance or supply security.

By tailoring reagents for ultra-low volume, miniaturised reactions while maintaining high quality, reproducible results, PACE Nano Genotyping Master Mix ensures the lowest costs per data point, making it one of the most high-performing, economical choices for high-throughput genotyping applications.

Is PACE Nano Genotyping Master Mix compatible with high-throughput workflows?

Absolutely! PACE Nano Genotyping reagents are designed to support high-throughput SNP genotyping and Indel genotyping across a variety of pipelines and workflows, ensuring consistent and reliable data.

What makes PACE Nano Genotyping Master Mix unique compared to other PCR genotyping products?

PACE Nano Genotyping Master Mix is specifically optimized for low and ultra-low volume PCR genotyping, offering improved performance, cost-efficiency, and scalability, backed by two decades of industry expertise. It is fully compatible with PACE Genotyping Assays plus other allele-specific PCR marker chemistries including KASP™ and Amplifluor®.

What reaction volumes does PACE Nano Genotyping Master Mix support?

PACE Nano Genotyping Master Mix supports reaction volumes down to ≤0.8 µL, offering unparalleled efficiency without compromising on data quality.

This field is for validation purposes and should be left unchanged.

Contact us


Steve Asquith Managing Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John Holme Technical Director
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base. During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Dr. Nisha JainOperations Director
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP. Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nazma Saffin General Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Jon Curtis Non-Executive Chair
After 8 years in The Royal Air Force, Jon moved to the Imperial Cancer Research Fund where he pioneered the use of ultra high-throughput genomic automation, capable of 46,000 PCRs per hour. In the 1990’s Jon joined GlaxoSmithKline, implementing a high-throughput genomics platform into their drug discovery pipeline. Whilst there he also developed acoustic mixing into compound management, becoming the gold standard across pharma. Jon developed the world’s first commercially viable 1536-well PCR plates, automated thermal & laser plate-sealer, plus automated liquid-handling & tip washing tools to reduce waste and costs. In 2002 Jon co-founded KBioscience with Phil Robinson, utilising ultra high-throughput PCR instrumentation & a suite of automation tools to create the company’s SNPline robotic platform, with a capacity of 250,000 PCRs/day. The business was underpinned by their ground-breaking patented genotyping chemistry, KASP™, which has over 10,000 scientific papers to date. In November 2022 Jon joined 3CR Bioscience acting as an advisor bringing his commercial and scientific experience to the company.